Clinical Trials Directory

Trials / Completed

CompletedNCT03988972

Efficacy of Diathermy on Healing Power of Cesarean Section Scar

Efficacy of Diathermy on Healing Power of Cesarean Section Scar:A Randomized Control Trail

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To compare the effects of electro-surgery on healing power as a primary outcome (from skin to the peritoneum. And volume of blood loss, incision time and postoperative surgical wound pain as secondary outcomes.

Detailed description

This is a prospective study is carried out at Ain Shams University Maternity Hospital, Obstetrics and Gynecology Department, Faculty of medicine in women undergoing CS through pfannentiel incisions. All women will receive intravenous antibiotic prophylaxis according to the Ain Shams guideline, 1 g of cefazolin given at the time of incision. Diathermy incisions will be carried out using monopolar blade pen electrode, set on cutting mode and delivering a 35 continuous current. Electrosurgical cutting will be performed without pressure or mechanical displacement. 'Bleeders' will be controlled by using diathermy, on coagulating mode, and will be applied to a hemostat on the vessels. Incisions made by the scalpel will be done by the traditional method, with proper hemostasis by application of pressure to skin blood vessels and by ligating the subcutaneous bleeders. After the operation and during the postoperative period, paracetamol (10mg/mL) 50-mL vial will be administered by i.v. infusion for analgesia on demand according to the patient's need with a 500-mg dose. And the wound will be sutured subcuticle by a prolene 3.0 sutures.

Conditions

Interventions

TypeNameDescription
DEVICEdiathermyIn women undergoing C.S, is healing power after diathermy equally to healing power after scalpel?
DEVICEscalpelIncisions made by the scalpel will be done by the traditional method, with proper hemostasis by application of pressure to skin blood vessels and by ligating the subcutaneous bleeders.

Timeline

Start date
2019-02-06
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2019-06-18
Last updated
2020-01-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03988972. Inclusion in this directory is not an endorsement.